Analyst Actions -- 9/21/2011

 | Sep 21, 2011 | 11:05 AM EDT  | Comments
  • Comment
  • Print Print
  • Print
Stock quotes in this article:

adbe

,

aapl

,

azo

,

jef

,

orcl

,

esrx

,

xlnx

,

ge

Adobe Systems estimates raised at Morgan Stanley

ADBE estimates were increased through 2012, Morgan Stanley said. Company boosted its guidance. Equal-weight rating.

-----

Adobe Systems estimates boosted at UBS

ADBE estimates increased through 2012, UBS said.  FQ4 guidance is upbeat, but potentially sets up a high bar.  Maintain $33 price target and Buy rating.

-----

Amdocs downgraded at JP Morgan

DOX was downgraded to Neutral, JP Morgan said. Company has outsized exposure to AT&T. $33 price target.            

-----

Apple estimates, target boosted at Goldman Sachs

Shares of AAPL now seen reaching $520, according to Goldman Sachs. Estimates also upped, as product demand should remain strong despite a weaker macro environment.

-----

Autodesk upgraded at JP Morgan

ADSK was upgraded to Overweight, JP Morgan said. Company is a high-quality cyclical play. $40 price target.

-----

AutoZone estimates, target raised at Citigroup

Shares of AZO now seen reaching $377, according to Citigroup.  Estimates also increased on slightly lower SG&A growth and encouraging conference call.  Buy rating.

-----

Autozone estimates, target upped at Goldman

AZO estimates were boosted through 2013, Goldman Sachs said. Company is cutting costs and buying back more stock. Sell rating and new $327 price target.

-----

Cabela's downgraded at JPMorgan

CAB was downgraded from Neutral to Underweight, JP Morgan said. New analyst sees lower profits in the financial services division. $22 price target.

-----

Carnival estimates lowered at UBS

CCL estimates lowered through 2012, UBS said.  Stronger dollar and higher fuel costs.  Maintain $40 price target and Buy rating.

-----

Express Scripts numbers cut at Jefferies

ESRX estimates were reduced through 2012, Jefferies said. Company is experiencing lower volume growth. Buy rating and new $55 price target.

-----

FedEx estimates, target cut at Sterne Agee

Shares of FDX now seen reaching $115, according to Sterne Agee.  Estimates also lowered on slower growth in Asia and domestic express volumes.  Maintain Buy rating.

-----

FedEx estimates, target cut at UBS

Shares of FDX now seen reaching $106, according to UBS.  Estimates also lowered on weaker global macro environment.  Maintain Buy rating.

-----

General Electric estimates lowered at Credit Suisse

GE estimates were cut through 2012, Credit Suisse said. Company is seeing lower Energy margins. Outperform rating and $22 price target.

-----

Hansen Natural estimates, target raised at UBS

Shares of HANS now seen reaching $110, according to UBS.  Estimates also increased on strong performance in Monster and new products.  Buy rating.

-----

Heico rated new Outperform at Credit Suisse

HEI was initiated with an Outperform rating, Credit Suisse said. $69 price target. Company is a strong after-market play that can gain market share.

-----

Jefferies numbers reduced at Goldman

JEF estimates were cut through 2013, Goldman Sachs said. Company tempered its growth expectations. Sell rating and new $13 price target.

-----

Jefferies downgraded at Ticonderoga

JEF was downgraded from Buy to Neutral, Ticonderoga said. Capital market activity could remain slow into 2012.

-----

Nordson estimates, target cut at BMO

Shares of NDSN now seen reaching $52, according to BMO Capital Markets.  Estimates also lowered as near term comps for sales and orders continue to be difficult.  Market Perform rating.

-----

NXP Semiconductors rated new Buy at Sterne Agee

NXPI was initiated with a Buy rating, Sterne Agee said.  $29 price target.  Improving FCF and debt.

-----

Oracle estimates increased at JP Morgan

ORCL estimates were raised through 2013, JP Morgan said. Company continues to grow in a difficult environment.

-----

Oracle estimates, target adjusted at Citigroup

Shares of ORCL now seen reaching $33, according to Citigroup.  Estimates adjusted through 2013, as hardware choppiness continues.  Buy rating.

-----

Oracle estimates increased at UBS

ORCL estimates increased through 2012, UBS said.  Solid FQ1 results despite the small blemish in hardware.  Maintain $37 price target and Buy rating.

-----

Philip Morris International estimates cut at Morgan Stanley

PM estimates were reduced through 2013, Morgan Stanley said. Company will face growth headwinds over the next several quarters. Overweight rating and $75 price target.

-----

PPL rated new Neutral at Credit Suisse

Coverage was started with a Neutral rating, Credit Suisse said. Valuation call, based on a $32 price target.

-----

Research in Motion target lowered at Jefferies

Shares of RIMM now seen reaching $21, according to Jefferies. Company has limited patent value and could trade down toward liquidation value. Underperform rating.

-----

Rovi upgraded at JP Morgan

ROVI was upgraded to Overweight, JP Morgan said. $60 price target. Stock is down 30% year-to-date and already pricing in consumer risk.

-----

Verisign downgraded at JP Morgan

VRSN was downgraded to Neutral, JP Morgan said. Valuation call, as the stock is up 84% over the past two years. $35 price target.

-----

Xilinx estimates reduced at Credit Suisse

XLNX estimates were cut through 2013, Credit Suisse said. Company is seeing lower communications and industrial demand. Neutral rating and $35 price target.

-----

Xilinx estimates lowered at UBS

XLNX estimates lowered through 2013, UBS said.  Weaker than expected communications, industrial sales.  Maintain $32 price target and Neutral rating.

Columnist Conversations

If this market has taught us one thing over the past 5 years, it has been to not be dogmatic in our views. Th...
Is this the biotech revolution or the biotech bust? View Small Cap Biotechs Like Never Before: Transparency is...
Market recovers a bit from early losses after European Bourses close at 11:30am EST. Upwardly revised Q2 GDP ...
When I do an article on a stock I do my best to define the risk on the trade. Sometimes I get to follow up an...

BEST IDEAS

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.